Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1987-11-09
1991-01-29
Garner, Vivian
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
562606, A61K 3100, C07C 53128
Patent
active
049887319
ABSTRACT:
This invention concerns certain diethyl- or dipropylacetic acid salts of sodium valproate which have physiological properties similar to those of valproic acid or sodium valproate but show highly superior stability characteristics.
REFERENCES:
patent: 2895976 (1959-07-01), Kairys et al.
patent: 2915537 (1959-12-01), Meade
patent: 4127604 (1978-11-01), Chignac et al.
patent: 4558070 (1985-12-01), Bauer et al.
"The Pharmacological Studies on Sodium Dipropylacetate Anticonvulsant Activities and General Pharmalogical Actions", K. Shuto and T. Nishigaki, Applied Pharmacology, 4[6], pp. 937-949 (1970).
Abbott Laboratories
Garner Vivian
Weinstock Steven F.
LandOfFree
Sodium hydrogen divalproate oligomer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sodium hydrogen divalproate oligomer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sodium hydrogen divalproate oligomer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-814278